Bumetanide
NDC 51672-4225, Bumetanide, tablet, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 51672-4225
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213458
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51672-4225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUMETANIDE2 mg/1
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51672-4225-1 | 51672422501 | 100 TABLET in 1 BOTTLE (51672-4225-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5c753aae-77b7-4add-8453-385a8f62d7dbNADAC price for package 51672422501
GET /v1/drugs/nadac/51672422501
Use it
Look up 51672-4225 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51672-4225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51672-4225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.